Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.27 USD | -3.70% | -3.70% | +7.41% |
08/05 | UBS raises Centrica to 'buy' from 'neutral | AN |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.96B 413B | Sales 2025 * | 4.27B 5.44B 453B | Capitalization | 3.91B 4.99B 415B |
---|---|---|---|---|---|
Net income 2024 * | 469M 598M 49.8B | Net income 2025 * | 504M 643M 53.52B | EV / Sales 2024 * | 1 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
8.4
x | P/E ratio 2025 * |
7.7
x | Employees | 3,000 |
Yield 2024 * |
2.83% | Yield 2025 * |
3.14% | Free-Float | 97.42% |
Latest transcript on Hiscox Ltd
1 day | -3.70% | ||
1 week | -3.70% | ||
Current month | -10.35% | ||
1 month | -4.91% | ||
3 months | +7.61% | ||
6 months | +20.45% | ||
Current year | +7.41% |
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 22/16/22 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 12/22/12 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 16/17/16 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 20/15/20 |
Colin Keogh
BRD | Director/Board Member | 69 | 19/15/19 |
Date | Price | Change | Volume |
---|---|---|---|
24/24/24 | 29.27 | -3.70% | 1,030 |
Delayed Quote OTC Markets, May 24, 2024 at 07:02 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.85% | 67.02B | |
+14.18% | 51.34B | |
+10.44% | 48.17B | |
+17.64% | 43.46B | |
+37.67% | 38.24B | |
+81.48% | 33.75B | |
+10.43% | 29.43B | |
+27.85% | 25.84B | |
+2.32% | 22.12B |
- Stock Market
- Equities
- HSX Stock
- HCXLY Stock